Tilray Q2 Earnings: What’s the Plan Here?

Another quarter, and another loss for Tilray Brands (TSX: TLRY) shareholders who are left wondering why they invested in the company in the first place.

Investors on Friday saw the equity sink as much as 15% after the release of the firms second quarter financial results, which were highlighted by single digit revenue growth that was offset by double-digit increases in net losses on a quarter over year basis.

The cannabis-turned distribution-turned alcohol brewer seems to be further away from profitability than ever, while attempting to woo investors by boasting about net revenue growth.

Lets dive in.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

One Response

  1. They have everything for success, they need a better planning team , I would get Palantir to make better judgments and then you’ll see profits, and when they legalize it we are going to be rolling in it 😉

Video Articles

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Is This the End of the Gold and Silver Rally? | Peter Grandich

Why Gold And Silver Stay High Even After Rate Cuts | Todd Bubba Horwitz

Recommended

TomaGold Confirms Presence Of Berrigan Deep Zone Following Geophysics

Antimony Resources Reports Massive Stibnite Mineralization Over 25 Metres At Marcus (West) Zone

Related News

Tilray Brands Posts Net Loss Of $85 Million In Q2 2025

Tilray Brands (TSX: TLRY) this morning reported its second quarter financial results, posting topline revenue...

Friday, January 10, 2025, 09:07:34 AM

Tilray, Aphria Closes $8.2 Billion Merger Arrangement

Tilray (NASDAQ: TLRY) and Aphria (TSX: APHA) (NASDAQ: APHA) have formally closed their previously announced...

Monday, May 3, 2021, 09:48:47 AM

Tilray Imports Medical Cannabis to USA to Assist Research on Breast Cancer Related Disorder

Tilray Inc (NASDAQ: TLRY) announced this morning that it has successfully imported medical cannabis from...

Thursday, October 24, 2019, 09:15:29 AM

Tilray Exchanges $72.9 Million In Convertible Notes For Shares At 42% Discount

Tilray Inc (NASDAQ: TLRY) has entered into an agreement to exchange $72.9 million worth of...

Tuesday, November 24, 2020, 09:31:31 AM

TIlray: Canaccord Resumes Coverage Following Aphria Transaction

Earlier this week, Tilray (NASDAQ: TLRY) finalized their merger with Aphria (NASDAQ: APHA) (TSX: APHA),...

Saturday, May 8, 2021, 04:20:00 PM